Strong Revenue Growth
BrightSpring Health Services reported a total revenue growth of 29% year-over-year for the fourth quarter, leading to total company revenue of $11.3 billion for the full year 2024, representing 28% growth.
Pharmacy Solutions Segment Performance
The Pharmacy Solutions segment revenue in the fourth quarter was $2.4 billion, achieving 34% year-over-year growth, with Infusion and Specialty revenue growing 42%.
Provider Services Segment Growth
Provider Services segment revenue was $656 million in the fourth quarter, representing 11% growth compared to the prior year period.
Adjusted EBITDA Growth
Adjusted EBITDA for the total company was $167 million in the fourth quarter, growing 17% compared to the fourth quarter of 2023. For full year 2024, adjusted EBITDA was $588 million, representing 16% growth.
Operational Efficiencies
BrightSpring has over 100 procurement, workflow augmentation, and automation programs completed or ongoing, driving process improvements and cost efficiencies.
Increased 2025 Guidance
BrightSpring increased total revenue and adjusted EBITDA guidance for 2025, with an adjusted EBITDA guidance increase by $5 million at both the low and high ends of the prior range.